|
?:authorAffiliation
|
-
[\'Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, 94110, USA. lloyd.chapman1@lshtm.ac.uk.\', \'Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. lloyd.chapman1@lshtm.ac.uk.\', \'Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, 94110, USA.\', \'Department of Medicine, University of California, San Francisco, San Francisco, CA, 94110, USA.\', \'Coronavirus Sciences Branch, California Department of Public Health, Richmond, CA, USA.\', \'Division of Pulmonary and Critical Care Medicine and Center for Tuberculosis, University of California, San Francisco, San Francisco, CA, USA.\', \'Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.\', \'Institute for Global Health Sciences, University of California, San Francisco, San Francisco, CA, USA.\', \'Immunization Branch, California Department of Public Health, Richmond, CA, USA.\', \'Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, 94110, USA. nathan.lo@ucsf.edu.\', \'Department of Medicine, University of California, San Francisco, San Francisco, CA, 94110, USA. nathan.lo@ucsf.edu.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}